Amanda Beth Chron, PharmD, MS

Successful #hopa2023 in the books! Congratulations to all presenters 👏 @HOPArx

Wrapped up breast rotation in the best way possible: presenting my grand rounds and decked out in pink 🎀

10K Time! Team #RunningOutOfDrugs representing at the @BAA 10K today, congrats to all, it was a hot one! #BAA10K #brighamandwomens @kait121 @LifewithLupi @lydia_ware @amandabethchron @PharmCritter @EricMGillett @shs_h10 @BWDionne @Tmaybury521

One more weekend staffing the ED 🚑, then that’s a wrap! @BrighamPharmacy thank you for the most enriching year, and congratulations to all of my amazing coresidents 🎉

“Although a higher incidence of thrombocytopenia, Ruxolitinib led to significant improvements in efficacy outcomes in patients with steroid-refractory aGVHD. Notably, tapering is required to avoid ruxolitinib discontinuation syndrome.”

3 weeks left in this residency year, the countdown is getting exciting! What's even more exciting is this great presentation by one of our PGY1 pharmacy residents, @amandabethchron - thanks Amanda, acute GVHD is super complex! #TwitteRx #PharmRes

@PharmCritter Congratulations, Anna! They are lucky to have you!

Excited to announce that after residency I will be joining Emory University Hospital as a Cardiology Clinical Pharmacy Specialist!! Boston will always have a special place in my heart and truly grateful for the last 2 years ❤️ ready for the new adventure in ATL!

Congratulations to our PGY-1 pharmacy residents who presented their longitudinal research projects at this year's Eastern States Conference! We're so proud of you! #EasternStates2022 #TwitteRx #PharmRes 🤩

“Hyperleukocytosis is a medical emergency that can lead to leukostasis, a hyperviscous state resulting in decreased organ perfusion and other complications. Management includes prompt cytoreduction and supportive care measures, in close consultation with an oncology service.”

Shout out to one of our amazing PGY-1 pharmacy residents, @amandabethchron, for a great presentation on a super complicated topic! Thanks Amanda! #TwitteRx #PharmRes

@SaraBanter @MSKCancerCenter Thank you! Congratulations are on order for you as well 🎉 excited for our next steps!

@amandabethchron @MSKCancerCenter Congratulations!! So happy for you!

Yesterday felt like a dream. I’m happy to share I’ll be heading to @MSKCancerCenter for my PGY2 in oncology! I have an army to thank, and I promise I’ll make you all proud 🙏 #ABCtakesNYC

@SaraBanter @heyjayeh @MDAndersonNews Congratulations!!

I’m going to be a hem/onc pharmacy specialist @MDAndersonNews!! See you in July, Houston 🤩 #MatchDay2022 #PharmRes #TwitteRx

@KallasDominic @TSM @TSM_Achieved @TSM_Pojoman @TSM_Beaulo @TSM_Merc @TSM_Geometrics @Chala_R6 @GotchaR6 @TSM_Daeda @TSMSmaK @TSMScales Amazing! Congrats @TSM 🎉🎉🎉

“The combination of pyrimethamine or sulfadiazine with atovaquone produced similar levels of overall treatment response compared to the standard of care. Patients with intolerance to an agent targeting toxoplasmosis have several options for alternative therapy.”

Big week for presentations! Thank you our great @amandabethchron for discussing toxoplasmosis encephalitis! It's as interesting as it is scary! #TwitteRx #PharmRes

Let's close the gap.

“Luspatercept-treated patients had a significantly greater percentage of reductions in transfusion burden vs. placebo. This will be a key therapy for transfusion-dependent (TD) beta-thalassemia patients, and is now being studied in non-TD patients.”

Happy Friday! Thanks to @amandabethchron for a super interesting case conference on beta thalassemia - such a cool topic!! #PharmRes #TwitteRx

So excited for what the future has in store for both you and TSM! Incredibly proud of this hardworking man 👏🏆